A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
Source: MedTech Dive
You may also like
Knee Pain? Ragged Cartilage? Research Suggests...
Lawmakers Look To Make Abortion Shield Laws Less...
Medtronic recalls heart valve delivery catheter for...
HistoSonics wins Europe’s CE mark for...
CVS Caremark reaches settlement with FTC over insulin...
HCA cuts 2026 earnings forecast on insurance coverage...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.